Seer Inc (SEER)
2.215
-0.02
(-1.12%)
USD |
NASDAQ |
May 07, 16:00
2.215
0.00 (0.00%)
After-Hours: 17:19
Seer Cash from Operations (TTM): -59.06M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -59.06M |
| September 30, 2023 | -63.13M |
| June 30, 2023 | -62.09M |
| March 31, 2023 | -60.96M |
| December 31, 2022 | -60.78M |
| September 30, 2022 | -58.89M |
| June 30, 2022 | -54.28M |
| Date | Value |
|---|---|
| March 31, 2022 | -50.63M |
| December 31, 2021 | -46.35M |
| September 30, 2021 | -39.46M |
| June 30, 2021 | -36.20M |
| March 31, 2021 | -30.63M |
| December 31, 2020 | -20.83M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-63.13M
Minimum
Sep 2023
-20.83M
Maximum
Dec 2020
-49.48M
Average
-54.28M
Median
Jun 2022
Cash from Operations (TTM) Benchmarks
| Candel Therapeutics Inc | -34.24M |
| CEL-SCI Corp | -23.07M |
| AIM ImmunoTech Inc | -21.27M |
| IGC Pharma Inc | -6.19M |
| NovaBay Pharmaceuticals Inc | -4.131M |